Reflecting on Merck’s I-O biomarker development journey

Immuno Oncology Insights ◽

10.18609/ioi.2021.008 ◽

2021 ◽

Vol 2 (3) ◽

pp. 115-121

Author(s):

Eric H Rubin, MD Eric H Rubin, MD

Download Full-text